Exact claim · Version 1 · Reviewed 2026-07-23
“Ipamorelin worked in its phase 2 surgical trial.”
A verdict on this wording and scope, not a universal grade for Ipamorelin.
01 · Verdict
Misleading
The randomized trial reported no significant difference from placebo on its key and secondary efficacy analyses.
- Evidence basis
- Randomized human outcomes
- Scope
- The postoperative-ileus population, intervention, and efficacy endpoints in the phase 2 trial.
- Category
- Clinical outcomes
02 · Primary record
Check the attached evidence
- Editorial review
- Internal editorial review recorded
- Responsible editor
- Anthony Treviso · Founder and responsible editor
- Clinical-review boundary
- Not independently medically reviewed.